Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Spinal Neoplasms | 27 | 2023 | 708 | 4.040 |
Why?
|
Thoracic Vertebrae | 24 | 2019 | 614 | 3.370 |
Why?
|
Lumbar Vertebrae | 31 | 2024 | 1873 | 3.010 |
Why?
|
Spinal Fusion | 27 | 2024 | 1302 | 2.560 |
Why?
|
Spinal Cord Injuries | 15 | 2019 | 927 | 2.350 |
Why?
|
Neurosurgical Procedures | 30 | 2024 | 2074 | 2.300 |
Why?
|
Laminectomy | 10 | 2019 | 226 | 2.020 |
Why?
|
Spinal Stenosis | 7 | 2024 | 257 | 1.970 |
Why?
|
Cervical Vertebrae | 11 | 2024 | 974 | 1.900 |
Why?
|
Spine | 18 | 2023 | 1128 | 1.900 |
Why?
|
Spondylolisthesis | 9 | 2024 | 173 | 1.840 |
Why?
|
Neurosurgery | 12 | 2019 | 683 | 1.750 |
Why?
|
Spinal Cord Neoplasms | 9 | 2016 | 258 | 1.630 |
Why?
|
Spinal Injuries | 13 | 2021 | 301 | 1.480 |
Why?
|
Spinal Cord Diseases | 6 | 2022 | 290 | 1.450 |
Why?
|
Spinal Cord Compression | 7 | 2019 | 234 | 1.420 |
Why?
|
Spinal Fractures | 13 | 2021 | 703 | 1.320 |
Why?
|
Pneumocephalus | 2 | 2020 | 46 | 1.310 |
Why?
|
Decompression, Surgical | 12 | 2024 | 603 | 1.300 |
Why?
|
Meningioma | 5 | 2024 | 1221 | 1.280 |
Why?
|
Meningeal Neoplasms | 5 | 2024 | 1252 | 1.250 |
Why?
|
Hematoma, Subdural, Chronic | 2 | 2020 | 98 | 1.230 |
Why?
|
Epidural Space | 4 | 2016 | 121 | 1.100 |
Why?
|
Radiculopathy | 4 | 2015 | 205 | 1.080 |
Why?
|
Astrocytoma | 6 | 2018 | 772 | 1.070 |
Why?
|
Facial Injuries | 2 | 2023 | 190 | 0.950 |
Why?
|
Sciatica | 2 | 2017 | 96 | 0.940 |
Why?
|
Neck Pain | 1 | 2024 | 190 | 0.820 |
Why?
|
Dura Mater | 3 | 2018 | 296 | 0.790 |
Why?
|
Nerve Regeneration | 3 | 2013 | 802 | 0.780 |
Why?
|
Gait | 3 | 2016 | 820 | 0.770 |
Why?
|
Spinal Diseases | 8 | 2017 | 559 | 0.770 |
Why?
|
Ependymoma | 4 | 2018 | 310 | 0.750 |
Why?
|
Neurofibromatosis 2 | 1 | 2024 | 387 | 0.720 |
Why?
|
Arachnoid Cysts | 2 | 2018 | 59 | 0.710 |
Why?
|
Lidocaine | 2 | 2014 | 550 | 0.710 |
Why?
|
Peripheral Nerves | 2 | 2015 | 491 | 0.630 |
Why?
|
Spondylosis | 1 | 2019 | 84 | 0.620 |
Why?
|
Chondrosarcoma | 2 | 2023 | 301 | 0.620 |
Why?
|
Epidural Neoplasms | 1 | 2018 | 23 | 0.620 |
Why?
|
Vertebroplasty | 2 | 2011 | 78 | 0.600 |
Why?
|
Craniotomy | 6 | 2020 | 730 | 0.590 |
Why?
|
Surgical Mesh | 1 | 2021 | 315 | 0.580 |
Why?
|
Recovery of Function | 5 | 2015 | 2966 | 0.560 |
Why?
|
Hemangioma, Cavernous | 1 | 2018 | 105 | 0.560 |
Why?
|
Communication Aids for Disabled | 1 | 2017 | 57 | 0.550 |
Why?
|
Anesthetics, Local | 2 | 2014 | 1015 | 0.550 |
Why?
|
Magnetic Resonance Imaging, Interventional | 1 | 2018 | 193 | 0.530 |
Why?
|
Spinal Cord | 5 | 2018 | 1784 | 0.520 |
Why?
|
Manipulation, Spinal | 1 | 2016 | 21 | 0.510 |
Why?
|
Medical Tourism | 1 | 2016 | 51 | 0.500 |
Why?
|
Humans | 148 | 2024 | 765968 | 0.500 |
Why?
|
Brain Injuries | 4 | 2013 | 2060 | 0.490 |
Why?
|
Glucocorticoids | 2 | 2015 | 2132 | 0.490 |
Why?
|
Odontoid Process | 2 | 2015 | 46 | 0.480 |
Why?
|
Stem Cell Transplantation | 4 | 2016 | 1602 | 0.480 |
Why?
|
Evidence-Based Medicine | 16 | 2021 | 3685 | 0.480 |
Why?
|
Bone Substitutes | 1 | 2017 | 229 | 0.480 |
Why?
|
Schwann Cells | 1 | 2015 | 195 | 0.460 |
Why?
|
Methylprednisolone | 2 | 2019 | 386 | 0.460 |
Why?
|
Myelin Proteins | 1 | 2015 | 212 | 0.450 |
Why?
|
Electric Stimulation Therapy | 3 | 2016 | 635 | 0.450 |
Why?
|
Epidural Abscess | 1 | 2015 | 96 | 0.430 |
Why?
|
Locomotion | 3 | 2012 | 384 | 0.430 |
Why?
|
Cryosurgery | 1 | 2018 | 479 | 0.420 |
Why?
|
Lumbosacral Region | 5 | 2021 | 295 | 0.420 |
Why?
|
Osteotomy | 2 | 2016 | 833 | 0.420 |
Why?
|
Pyramidal Tracts | 1 | 2015 | 249 | 0.420 |
Why?
|
Fractures, Spontaneous | 2 | 2019 | 230 | 0.410 |
Why?
|
Neurilemmoma | 1 | 2018 | 522 | 0.400 |
Why?
|
Corynebacterium Infections | 1 | 2011 | 27 | 0.380 |
Why?
|
Simvastatin | 1 | 2014 | 345 | 0.380 |
Why?
|
Insurance, Liability | 1 | 2011 | 100 | 0.360 |
Why?
|
Intracranial Pressure | 1 | 2013 | 322 | 0.360 |
Why?
|
Bone Morphogenetic Protein 2 | 2 | 2014 | 343 | 0.350 |
Why?
|
Cerebral Arteries | 2 | 2012 | 490 | 0.350 |
Why?
|
Decompressive Craniectomy | 1 | 2011 | 76 | 0.350 |
Why?
|
Spleen | 1 | 2016 | 2296 | 0.350 |
Why?
|
Subdural Space | 2 | 2020 | 38 | 0.340 |
Why?
|
Chondroitin ABC Lyase | 1 | 2010 | 15 | 0.340 |
Why?
|
Treatment Outcome | 31 | 2024 | 65188 | 0.340 |
Why?
|
Magnetic Field Therapy | 1 | 2010 | 27 | 0.340 |
Why?
|
Randomized Controlled Trials as Topic | 9 | 2016 | 10383 | 0.340 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2012 | 633 | 0.330 |
Why?
|
Fractures, Compression | 2 | 2011 | 132 | 0.330 |
Why?
|
Off-Label Use | 1 | 2011 | 185 | 0.330 |
Why?
|
Secondary Prevention | 1 | 2016 | 1472 | 0.330 |
Why?
|
Muscle Contraction | 1 | 2014 | 1206 | 0.320 |
Why?
|
Abscess | 2 | 2022 | 606 | 0.320 |
Why?
|
Hemangioblastoma | 3 | 2006 | 63 | 0.320 |
Why?
|
Hemangioma | 3 | 2016 | 723 | 0.320 |
Why?
|
Low Back Pain | 3 | 2016 | 987 | 0.310 |
Why?
|
Diagnostic Imaging | 3 | 2012 | 3529 | 0.310 |
Why?
|
Serotonin Receptor Agonists | 1 | 2009 | 151 | 0.310 |
Why?
|
Paralysis | 1 | 2010 | 248 | 0.310 |
Why?
|
Diphosphonates | 1 | 2013 | 625 | 0.310 |
Why?
|
Vancomycin | 1 | 2012 | 504 | 0.310 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2013 | 504 | 0.300 |
Why?
|
Pain, Postoperative | 3 | 2019 | 1772 | 0.300 |
Why?
|
Postoperative Complications | 10 | 2020 | 15747 | 0.300 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 1 | 2010 | 170 | 0.290 |
Why?
|
Hematoma | 1 | 2012 | 766 | 0.280 |
Why?
|
Aged | 42 | 2024 | 171117 | 0.280 |
Why?
|
Hindlimb | 1 | 2009 | 510 | 0.280 |
Why?
|
Monitoring, Physiologic | 2 | 2013 | 1792 | 0.280 |
Why?
|
Internal Fixators | 4 | 2021 | 183 | 0.280 |
Why?
|
Motor Cortex | 1 | 2015 | 1003 | 0.280 |
Why?
|
ADP-Ribosylation Factors | 1 | 2008 | 130 | 0.280 |
Why?
|
Nucleic Acids | 1 | 2010 | 193 | 0.280 |
Why?
|
Diskectomy | 2 | 2013 | 201 | 0.280 |
Why?
|
Multicenter Studies as Topic | 4 | 2013 | 1731 | 0.270 |
Why?
|
Cerebral Angiography | 1 | 2012 | 1262 | 0.270 |
Why?
|
Malpractice | 1 | 2011 | 561 | 0.270 |
Why?
|
Middle Aged | 44 | 2024 | 223009 | 0.270 |
Why?
|
Conflict of Interest | 1 | 2011 | 556 | 0.270 |
Why?
|
Male | 54 | 2024 | 363698 | 0.260 |
Why?
|
Posterior Cerebral Artery | 1 | 2006 | 34 | 0.260 |
Why?
|
Bone Density Conservation Agents | 1 | 2013 | 791 | 0.260 |
Why?
|
Female | 59 | 2024 | 396112 | 0.260 |
Why?
|
Tomography, Optical Coherence | 1 | 2019 | 2932 | 0.260 |
Why?
|
Neuroprotective Agents | 1 | 2012 | 959 | 0.260 |
Why?
|
Cerebrospinal Fluid Rhinorrhea | 1 | 2006 | 86 | 0.250 |
Why?
|
Sphenoid Sinus | 1 | 2006 | 100 | 0.250 |
Why?
|
Paraplegia | 2 | 2016 | 158 | 0.250 |
Why?
|
Glioma | 4 | 2016 | 3493 | 0.250 |
Why?
|
Patient Education as Topic | 1 | 2016 | 2334 | 0.250 |
Why?
|
Adult | 37 | 2024 | 223044 | 0.240 |
Why?
|
Motor Activity | 1 | 2014 | 2704 | 0.230 |
Why?
|
Occipital Lobe | 1 | 2006 | 376 | 0.230 |
Why?
|
Sufentanil | 1 | 2024 | 44 | 0.230 |
Why?
|
Neurology | 1 | 2012 | 785 | 0.220 |
Why?
|
Guidelines as Topic | 9 | 2019 | 1394 | 0.220 |
Why?
|
Brain Neoplasms | 7 | 2016 | 9071 | 0.220 |
Why?
|
Joint Prosthesis | 1 | 2005 | 233 | 0.220 |
Why?
|
Cranial Fossa, Anterior | 1 | 2003 | 13 | 0.220 |
Why?
|
Retrospective Studies | 27 | 2024 | 81514 | 0.220 |
Why?
|
Transforming Growth Factor beta | 1 | 2011 | 1995 | 0.220 |
Why?
|
Carotid Artery, Internal | 1 | 2006 | 437 | 0.220 |
Why?
|
Practice Guidelines as Topic | 4 | 2016 | 7425 | 0.210 |
Why?
|
Patient Care Planning | 2 | 2019 | 906 | 0.210 |
Why?
|
Neuralgia | 1 | 2010 | 625 | 0.210 |
Why?
|
Preoperative Care | 3 | 2020 | 2267 | 0.200 |
Why?
|
Surgical Wound Infection | 1 | 2012 | 1543 | 0.200 |
Why?
|
Radiation Dosage | 1 | 2011 | 1944 | 0.200 |
Why?
|
Arthrodesis | 3 | 2019 | 186 | 0.200 |
Why?
|
Back Pain | 3 | 2022 | 544 | 0.200 |
Why?
|
Streptococcus anginosus | 1 | 2022 | 25 | 0.200 |
Why?
|
Brain Edema | 1 | 2006 | 602 | 0.200 |
Why?
|
Disability Evaluation | 2 | 2024 | 1820 | 0.190 |
Why?
|
PTEN Phosphohydrolase | 1 | 2008 | 1119 | 0.190 |
Why?
|
Arthroplasty, Replacement | 1 | 2005 | 314 | 0.190 |
Why?
|
Vascular Surgical Procedures | 3 | 2008 | 1485 | 0.190 |
Why?
|
Neurofibromatoses | 1 | 2006 | 303 | 0.190 |
Why?
|
Pain Measurement | 4 | 2024 | 3561 | 0.190 |
Why?
|
Rats | 9 | 2016 | 23707 | 0.190 |
Why?
|
Skin | 1 | 2015 | 4489 | 0.190 |
Why?
|
Prognosis | 7 | 2024 | 29922 | 0.180 |
Why?
|
Biopsy | 1 | 2013 | 6763 | 0.180 |
Why?
|
Cerebral Hemorrhage | 1 | 2012 | 2648 | 0.180 |
Why?
|
Occupational Exposure | 1 | 2011 | 1805 | 0.180 |
Why?
|
Hypotension | 1 | 2006 | 885 | 0.180 |
Why?
|
Antigens, Neoplasm | 2 | 2008 | 2002 | 0.170 |
Why?
|
Ossification of Posterior Longitudinal Ligament | 1 | 2019 | 17 | 0.170 |
Why?
|
Computers, Handheld | 1 | 2022 | 211 | 0.170 |
Why?
|
Wounds, Nonpenetrating | 1 | 2006 | 807 | 0.170 |
Why?
|
Frontal Lobe | 1 | 2006 | 1410 | 0.170 |
Why?
|
Orthopedic Procedures | 4 | 2018 | 1280 | 0.170 |
Why?
|
Hydrocephalus | 2 | 2009 | 762 | 0.170 |
Why?
|
Scoliosis | 1 | 2007 | 789 | 0.170 |
Why?
|
Intracranial Aneurysm | 2 | 2006 | 1272 | 0.160 |
Why?
|
Bone Neoplasms | 1 | 2011 | 2567 | 0.160 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 3251 | 0.160 |
Why?
|
Animals | 20 | 2016 | 168764 | 0.160 |
Why?
|
Research Design | 2 | 2012 | 6209 | 0.160 |
Why?
|
Cadaver | 2 | 2022 | 1359 | 0.150 |
Why?
|
Subarachnoid Space | 1 | 2018 | 77 | 0.150 |
Why?
|
Prospective Studies | 11 | 2024 | 54802 | 0.150 |
Why?
|
Magnetic Resonance Imaging | 15 | 2024 | 36532 | 0.140 |
Why?
|
Tomography, X-Ray Computed | 9 | 2019 | 20659 | 0.140 |
Why?
|
Walking | 2 | 2019 | 1198 | 0.140 |
Why?
|
Pain | 4 | 2018 | 5077 | 0.140 |
Why?
|
Combined Modality Therapy | 3 | 2023 | 8529 | 0.140 |
Why?
|
Bone Nails | 3 | 2007 | 222 | 0.140 |
Why?
|
Punctures | 1 | 2018 | 373 | 0.140 |
Why?
|
Chordoma | 2 | 2012 | 343 | 0.140 |
Why?
|
Prostheses and Implants | 3 | 2021 | 1273 | 0.130 |
Why?
|
Injections, Spinal | 2 | 2024 | 310 | 0.130 |
Why?
|
Arthroplasty | 3 | 2024 | 306 | 0.130 |
Why?
|
Patient Selection | 4 | 2018 | 4255 | 0.130 |
Why?
|
Genetic Predisposition to Disease | 2 | 2017 | 18071 | 0.130 |
Why?
|
Vision Disorders | 1 | 2003 | 1087 | 0.130 |
Why?
|
Aged, 80 and over | 14 | 2022 | 59489 | 0.130 |
Why?
|
Neurologic Examination | 1 | 2019 | 912 | 0.120 |
Why?
|
Blood Loss, Surgical | 1 | 2019 | 629 | 0.120 |
Why?
|
Analgesics, Opioid | 2 | 2024 | 3835 | 0.120 |
Why?
|
Multivariate Analysis | 3 | 2019 | 12056 | 0.120 |
Why?
|
Fracture Fixation, Internal | 2 | 2019 | 982 | 0.120 |
Why?
|
Vascular Neoplasms | 1 | 2016 | 167 | 0.110 |
Why?
|
Osteomyelitis | 1 | 2018 | 408 | 0.110 |
Why?
|
Glioblastoma | 2 | 2016 | 3459 | 0.110 |
Why?
|
Biopsy, Needle | 1 | 2019 | 1628 | 0.110 |
Why?
|
Morphine | 1 | 2018 | 660 | 0.110 |
Why?
|
Neuroendoscopy | 1 | 2015 | 93 | 0.110 |
Why?
|
Medulla Oblongata | 1 | 2015 | 246 | 0.110 |
Why?
|
Therapeutic Irrigation | 1 | 2015 | 297 | 0.110 |
Why?
|
Anti-Bacterial Agents | 1 | 2012 | 7478 | 0.110 |
Why?
|
Sulfotransferases | 1 | 2014 | 151 | 0.110 |
Why?
|
Injections, Epidural | 1 | 2015 | 204 | 0.100 |
Why?
|
Physicians | 1 | 2011 | 4588 | 0.100 |
Why?
|
Glasgow Coma Scale | 2 | 2021 | 575 | 0.100 |
Why?
|
Age Distribution | 3 | 2009 | 2858 | 0.100 |
Why?
|
Geriatric Assessment | 1 | 2020 | 1429 | 0.100 |
Why?
|
Aging | 2 | 2009 | 8731 | 0.100 |
Why?
|
Constriction, Pathologic | 3 | 2022 | 1105 | 0.100 |
Why?
|
Body Temperature | 1 | 2016 | 779 | 0.100 |
Why?
|
Disease Models, Animal | 4 | 2014 | 18293 | 0.100 |
Why?
|
Spinal Cord Vascular Diseases | 1 | 2012 | 9 | 0.100 |
Why?
|
Young Adult | 11 | 2022 | 59889 | 0.100 |
Why?
|
Imaging, Three-Dimensional | 2 | 2024 | 4034 | 0.100 |
Why?
|
Thromboembolism | 1 | 2019 | 1003 | 0.100 |
Why?
|
Powders | 1 | 2012 | 78 | 0.100 |
Why?
|
Fluoroscopy | 2 | 2018 | 947 | 0.100 |
Why?
|
Pneumonectomy | 2 | 2016 | 1128 | 0.100 |
Why?
|
Giant Cell Tumors | 1 | 2012 | 89 | 0.090 |
Why?
|
Cohort Studies | 7 | 2024 | 41649 | 0.090 |
Why?
|
Analgesics | 1 | 2018 | 1060 | 0.090 |
Why?
|
Logistic Models | 3 | 2019 | 13266 | 0.090 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2024 | 9373 | 0.090 |
Why?
|
Lung Neoplasms | 4 | 2019 | 13451 | 0.090 |
Why?
|
Predictive Value of Tests | 5 | 2020 | 15398 | 0.090 |
Why?
|
Angiography, Digital Subtraction | 1 | 2012 | 332 | 0.090 |
Why?
|
Exophthalmos | 1 | 2011 | 99 | 0.090 |
Why?
|
User-Computer Interface | 1 | 2017 | 1405 | 0.090 |
Why?
|
Models, Chemical | 1 | 2012 | 608 | 0.090 |
Why?
|
Observation | 1 | 2012 | 309 | 0.090 |
Why?
|
Joint Instability | 1 | 2018 | 802 | 0.090 |
Why?
|
Medical Illustration | 2 | 2008 | 134 | 0.090 |
Why?
|
Physician-Patient Relations | 1 | 2023 | 3278 | 0.090 |
Why?
|
Radiotherapy | 3 | 2017 | 1494 | 0.080 |
Why?
|
Glial Cell Line-Derived Neurotrophic Factor | 1 | 2010 | 66 | 0.080 |
Why?
|
Brain | 2 | 2017 | 27171 | 0.080 |
Why?
|
Mortality | 2 | 2019 | 2904 | 0.080 |
Why?
|
Carcinoma | 2 | 2019 | 2312 | 0.080 |
Why?
|
Efferent Pathways | 1 | 2010 | 164 | 0.080 |
Why?
|
Pinealoma | 1 | 2009 | 51 | 0.080 |
Why?
|
Weight-Bearing | 2 | 2009 | 529 | 0.080 |
Why?
|
Risk Factors | 7 | 2024 | 74840 | 0.080 |
Why?
|
Motor Neurons | 1 | 2014 | 869 | 0.080 |
Why?
|
Neural Stem Cells | 1 | 2016 | 898 | 0.080 |
Why?
|
Disease Management | 1 | 2019 | 2535 | 0.080 |
Why?
|
Glycosaminoglycans | 1 | 2012 | 606 | 0.080 |
Why?
|
Time | 2 | 2020 | 550 | 0.080 |
Why?
|
Delirium | 1 | 2020 | 1707 | 0.080 |
Why?
|
Pineal Gland | 1 | 2009 | 153 | 0.080 |
Why?
|
Hemifacial Spasm | 1 | 2008 | 23 | 0.080 |
Why?
|
Databases, Factual | 2 | 2014 | 8067 | 0.080 |
Why?
|
Watchful Waiting | 1 | 2013 | 493 | 0.080 |
Why?
|
Infusions, Intravenous | 1 | 2013 | 2229 | 0.080 |
Why?
|
Cerebellopontine Angle | 1 | 2008 | 53 | 0.080 |
Why?
|
Electromagnetic Fields | 1 | 2010 | 290 | 0.080 |
Why?
|
Blotting, Northern | 2 | 2008 | 1546 | 0.070 |
Why?
|
Reoperation | 2 | 2016 | 4294 | 0.070 |
Why?
|
Hemodynamics | 1 | 2019 | 4184 | 0.070 |
Why?
|
Polyribosomes | 1 | 2008 | 109 | 0.070 |
Why?
|
Bone Morphogenetic Proteins | 2 | 2011 | 844 | 0.070 |
Why?
|
Electromyography | 2 | 2009 | 1399 | 0.070 |
Why?
|
Genomics | 1 | 2023 | 5929 | 0.070 |
Why?
|
Recurrence | 1 | 2020 | 8501 | 0.070 |
Why?
|
Prevalence | 1 | 2024 | 15842 | 0.070 |
Why?
|
Survival Analysis | 5 | 2023 | 10070 | 0.070 |
Why?
|
Ribs | 1 | 2008 | 254 | 0.070 |
Why?
|
Cranial Fossa, Middle | 1 | 2006 | 29 | 0.070 |
Why?
|
Principal Component Analysis | 1 | 2009 | 951 | 0.070 |
Why?
|
Lipoma | 1 | 2008 | 294 | 0.070 |
Why?
|
Bone Screws | 2 | 2007 | 532 | 0.070 |
Why?
|
Temporal Muscle | 1 | 2006 | 36 | 0.070 |
Why?
|
Gravitation | 1 | 2006 | 82 | 0.070 |
Why?
|
Brain Abscess | 1 | 2007 | 118 | 0.060 |
Why?
|
Calcium Channels | 1 | 2010 | 622 | 0.060 |
Why?
|
Pain Threshold | 1 | 2010 | 604 | 0.060 |
Why?
|
Hyperalgesia | 1 | 2010 | 514 | 0.060 |
Why?
|
Sella Turcica | 1 | 2006 | 117 | 0.060 |
Why?
|
Tissue Transplantation | 1 | 2006 | 128 | 0.060 |
Why?
|
Hemangioma, Cavernous, Central Nervous System | 1 | 2006 | 58 | 0.060 |
Why?
|
Sex Distribution | 2 | 2008 | 2263 | 0.060 |
Why?
|
Hematoma, Subdural, Spinal | 1 | 2005 | 8 | 0.060 |
Why?
|
Sphenoid Bone | 1 | 2006 | 176 | 0.060 |
Why?
|
Genes, ras | 1 | 2008 | 658 | 0.060 |
Why?
|
Quality Improvement | 2 | 2020 | 3853 | 0.060 |
Why?
|
Follow-Up Studies | 6 | 2018 | 39193 | 0.060 |
Why?
|
Algorithms | 1 | 2005 | 14071 | 0.060 |
Why?
|
Trauma Severity Indices | 1 | 2006 | 479 | 0.060 |
Why?
|
von Hippel-Lindau Disease | 1 | 2006 | 154 | 0.060 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2012 | 1657 | 0.060 |
Why?
|
Video Recording | 1 | 2009 | 969 | 0.060 |
Why?
|
Time Factors | 5 | 2016 | 40065 | 0.060 |
Why?
|
Stents | 1 | 2016 | 3213 | 0.060 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2008 | 679 | 0.060 |
Why?
|
Diagnosis, Differential | 2 | 2018 | 12976 | 0.060 |
Why?
|
Reflex Sympathetic Dystrophy | 1 | 2024 | 60 | 0.060 |
Why?
|
Reproducibility of Results | 1 | 2022 | 20124 | 0.050 |
Why?
|
Cicatrix | 1 | 2010 | 798 | 0.050 |
Why?
|
Cerebellar Neoplasms | 1 | 2008 | 571 | 0.050 |
Why?
|
Review Literature as Topic | 1 | 2005 | 297 | 0.050 |
Why?
|
Spinal Nerve Roots | 1 | 2023 | 122 | 0.050 |
Why?
|
Oximetry | 1 | 2006 | 459 | 0.050 |
Why?
|
Infusion Pumps, Implantable | 1 | 2024 | 158 | 0.050 |
Why?
|
Spinal Dysraphism | 1 | 2005 | 179 | 0.050 |
Why?
|
Arteriovenous Malformations | 1 | 2006 | 397 | 0.050 |
Why?
|
Breast Neoplasms | 4 | 2019 | 21056 | 0.050 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2005 | 345 | 0.050 |
Why?
|
Arteriovenous Fistula | 1 | 2006 | 311 | 0.050 |
Why?
|
Brain Ischemia | 1 | 2016 | 3000 | 0.050 |
Why?
|
Emergency Treatment | 1 | 2006 | 494 | 0.050 |
Why?
|
Communication | 1 | 2017 | 3916 | 0.050 |
Why?
|
Decision Making | 1 | 2016 | 3965 | 0.050 |
Why?
|
Cross-Sectional Studies | 1 | 2023 | 26318 | 0.050 |
Why?
|
Blotting, Western | 2 | 2008 | 5020 | 0.050 |
Why?
|
Zygapophyseal Joint | 1 | 2024 | 129 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 2 | 2011 | 6499 | 0.050 |
Why?
|
Patient Readmission | 1 | 2016 | 3286 | 0.050 |
Why?
|
Endovascular Procedures | 1 | 2016 | 2222 | 0.050 |
Why?
|
Recombinant Proteins | 1 | 2011 | 6493 | 0.050 |
Why?
|
Length of Stay | 2 | 2020 | 6485 | 0.050 |
Why?
|
Exercise Test | 1 | 2009 | 2180 | 0.050 |
Why?
|
Neuronal Plasticity | 1 | 2010 | 1445 | 0.050 |
Why?
|
Risk Assessment | 5 | 2020 | 24282 | 0.050 |
Why?
|
Electroencephalography | 1 | 2017 | 6273 | 0.050 |
Why?
|
Gliosarcoma | 1 | 2001 | 116 | 0.050 |
Why?
|
Adolescent | 9 | 2022 | 88835 | 0.050 |
Why?
|
Patient Discharge | 1 | 2014 | 3461 | 0.050 |
Why?
|
RNA, Small Interfering | 1 | 2010 | 3421 | 0.040 |
Why?
|
Sirolimus | 1 | 2008 | 1545 | 0.040 |
Why?
|
Thymidine Kinase | 2 | 2016 | 286 | 0.040 |
Why?
|
Longitudinal Ligaments | 1 | 2019 | 25 | 0.040 |
Why?
|
Acute Disease | 1 | 2010 | 7232 | 0.040 |
Why?
|
Astrocytes | 1 | 2008 | 1345 | 0.040 |
Why?
|
Functional Laterality | 1 | 2006 | 2243 | 0.040 |
Why?
|
Point Mutation | 1 | 2005 | 1590 | 0.040 |
Why?
|
Arthritis, Rheumatoid | 1 | 2015 | 3733 | 0.040 |
Why?
|
Intraoperative Complications | 1 | 2006 | 1162 | 0.040 |
Why?
|
Neuroimmunomodulation | 1 | 2001 | 186 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2008 | 2453 | 0.040 |
Why?
|
Agrin | 1 | 1999 | 75 | 0.040 |
Why?
|
Neoplasms | 1 | 2008 | 22340 | 0.040 |
Why?
|
Major Histocompatibility Complex | 1 | 2001 | 879 | 0.040 |
Why?
|
England | 1 | 2020 | 533 | 0.040 |
Why?
|
Intraoperative Period | 1 | 2019 | 508 | 0.040 |
Why?
|
International Classification of Diseases | 2 | 2014 | 935 | 0.040 |
Why?
|
Polymerase Chain Reaction | 1 | 2008 | 6069 | 0.040 |
Why?
|
Adenocarcinoma | 1 | 2016 | 6364 | 0.040 |
Why?
|
Prosthesis Design | 1 | 2005 | 2105 | 0.040 |
Why?
|
Receptors, Cholinergic | 1 | 1999 | 243 | 0.040 |
Why?
|
Perioperative Period | 1 | 2019 | 251 | 0.040 |
Why?
|
Peptides | 1 | 2010 | 4331 | 0.040 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2016 | 3608 | 0.040 |
Why?
|
Antineoplastic Agents | 2 | 2019 | 13648 | 0.040 |
Why?
|
Neoplasm Invasiveness | 2 | 2016 | 3602 | 0.040 |
Why?
|
Lymphocyte Count | 1 | 2019 | 790 | 0.040 |
Why?
|
Flucytosine | 1 | 2016 | 31 | 0.030 |
Why?
|
Platelet Count | 1 | 2019 | 782 | 0.030 |
Why?
|
Calcium | 1 | 2010 | 5767 | 0.030 |
Why?
|
Radiography | 2 | 2008 | 6919 | 0.030 |
Why?
|
Anticoagulants | 2 | 2019 | 4862 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2007 | 5302 | 0.030 |
Why?
|
Cytosine Deaminase | 1 | 2016 | 63 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2016 | 17075 | 0.030 |
Why?
|
Rats, Wistar | 1 | 2000 | 1884 | 0.030 |
Why?
|
HSP27 Heat-Shock Proteins | 1 | 2016 | 67 | 0.030 |
Why?
|
Enterobiasis | 1 | 1995 | 1 | 0.030 |
Why?
|
Ganciclovir | 1 | 2016 | 257 | 0.030 |
Why?
|
Frail Elderly | 1 | 2020 | 785 | 0.030 |
Why?
|
Analgesia, Epidural | 1 | 2018 | 337 | 0.030 |
Why?
|
RNA, Messenger | 1 | 2010 | 12768 | 0.030 |
Why?
|
Bupivacaine | 1 | 2018 | 432 | 0.030 |
Why?
|
Bone Transplantation | 2 | 2013 | 920 | 0.030 |
Why?
|
Postoperative Period | 1 | 2019 | 1816 | 0.030 |
Why?
|
Menarche | 1 | 1997 | 532 | 0.030 |
Why?
|
Enterocolitis | 1 | 1995 | 107 | 0.030 |
Why?
|
Transcription, Genetic | 1 | 2008 | 7599 | 0.030 |
Why?
|
Braces | 1 | 2014 | 139 | 0.030 |
Why?
|
Treatment Failure | 1 | 2019 | 2652 | 0.030 |
Why?
|
Risk | 1 | 2005 | 9591 | 0.030 |
Why?
|
Child | 4 | 2022 | 80564 | 0.030 |
Why?
|
Comorbidity | 1 | 2008 | 10563 | 0.030 |
Why?
|
Quality of Life | 2 | 2019 | 13462 | 0.030 |
Why?
|
United States | 5 | 2020 | 72903 | 0.030 |
Why?
|
Heat-Shock Proteins | 1 | 2016 | 791 | 0.020 |
Why?
|
Infant | 2 | 2022 | 36386 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2008 | 8611 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2020 | 2354 | 0.020 |
Why?
|
Fluorouracil | 1 | 2016 | 1648 | 0.020 |
Why?
|
Child, Preschool | 2 | 2022 | 42500 | 0.020 |
Why?
|
Nose | 1 | 2015 | 519 | 0.020 |
Why?
|
Radiotherapy Dosage | 1 | 2018 | 2865 | 0.020 |
Why?
|
Medicare Part A | 1 | 2011 | 40 | 0.020 |
Why?
|
Eosinophilia | 1 | 1995 | 556 | 0.020 |
Why?
|
Genetic Engineering | 1 | 2016 | 933 | 0.020 |
Why?
|
Lymphoma | 1 | 2019 | 1897 | 0.020 |
Why?
|
Rats, Inbred F344 | 2 | 2001 | 822 | 0.020 |
Why?
|
Aorta, Thoracic | 1 | 2016 | 1103 | 0.020 |
Why?
|
Vestibulocochlear Nerve | 1 | 2008 | 115 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2019 | 4893 | 0.020 |
Why?
|
Ventriculostomy | 1 | 2009 | 127 | 0.020 |
Why?
|
Neoplastic Stem Cells | 1 | 2016 | 1352 | 0.020 |
Why?
|
Diplopia | 1 | 2009 | 217 | 0.020 |
Why?
|
Incidence | 2 | 2020 | 21480 | 0.020 |
Why?
|
Polytetrafluoroethylene | 1 | 2008 | 238 | 0.020 |
Why?
|
Hospital Charges | 1 | 2009 | 345 | 0.020 |
Why?
|
Mice | 1 | 2014 | 81819 | 0.020 |
Why?
|
Evoked Potentials, Auditory, Brain Stem | 1 | 2008 | 256 | 0.020 |
Why?
|
Insurance Claim Review | 1 | 2011 | 746 | 0.020 |
Why?
|
Orthopedic Fixation Devices | 1 | 2007 | 76 | 0.020 |
Why?
|
Health Status | 1 | 2019 | 4080 | 0.020 |
Why?
|
Orthotic Devices | 1 | 2007 | 131 | 0.020 |
Why?
|
Facial Nerve | 1 | 2008 | 277 | 0.020 |
Why?
|
Sacrum | 1 | 2008 | 270 | 0.020 |
Why?
|
Rotavirus | 1 | 1987 | 110 | 0.020 |
Why?
|
Survival Rate | 2 | 2011 | 12795 | 0.020 |
Why?
|
Genes, Neurofibromatosis 2 | 1 | 2005 | 122 | 0.010 |
Why?
|
Immunotherapy | 1 | 2000 | 4752 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2018 | 12437 | 0.010 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2005 | 274 | 0.010 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2005 | 348 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2019 | 4353 | 0.010 |
Why?
|
Pregnancy | 1 | 2005 | 30260 | 0.010 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2005 | 416 | 0.010 |
Why?
|
Mutation | 1 | 2008 | 30198 | 0.010 |
Why?
|
Drug Utilization | 1 | 2009 | 1187 | 0.010 |
Why?
|
Inpatients | 1 | 2014 | 2564 | 0.010 |
Why?
|
California | 1 | 2007 | 1436 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18380 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2022 | 26346 | 0.010 |
Why?
|
Transfection | 2 | 2001 | 5743 | 0.010 |
Why?
|
Cytomegalovirus | 1 | 1987 | 751 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2008 | 2844 | 0.010 |
Why?
|
Blood Vessels | 1 | 2008 | 1113 | 0.010 |
Why?
|
Monitoring, Intraoperative | 1 | 2008 | 936 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2019 | 8923 | 0.010 |
Why?
|
Antigenic Modulation | 1 | 2001 | 11 | 0.010 |
Why?
|
Multiple Myeloma | 1 | 2019 | 5197 | 0.010 |
Why?
|
Medical Records | 1 | 2007 | 1409 | 0.010 |
Why?
|
Hearing Loss | 1 | 2008 | 784 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2016 | 11206 | 0.010 |
Why?
|
Topotecan | 1 | 2000 | 130 | 0.010 |
Why?
|
Registries | 1 | 2016 | 8297 | 0.010 |
Why?
|
Apoptosis | 1 | 2016 | 9514 | 0.010 |
Why?
|
Chromatography, Agarose | 1 | 1999 | 29 | 0.010 |
Why?
|
Receptor Aggregation | 1 | 1999 | 71 | 0.010 |
Why?
|
Rectal Neoplasms | 1 | 2008 | 1182 | 0.010 |
Why?
|
Microsurgery | 1 | 2005 | 795 | 0.010 |
Why?
|
Linear Models | 1 | 2009 | 5876 | 0.010 |
Why?
|
Staphylococcus aureus | 1 | 2007 | 1424 | 0.010 |
Why?
|
Range of Motion, Articular | 1 | 2005 | 1594 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2011 | 5526 | 0.010 |
Why?
|
Staphylococcal Infections | 1 | 2007 | 1393 | 0.010 |
Why?
|
Basement Membrane | 1 | 1999 | 349 | 0.010 |
Why?
|
Embolization, Therapeutic | 1 | 2008 | 1403 | 0.010 |
Why?
|
Simplexvirus | 1 | 2001 | 807 | 0.010 |
Why?
|
Epidemiologic Factors | 1 | 1997 | 36 | 0.010 |
Why?
|
COS Cells | 1 | 1999 | 1136 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2011 | 12509 | 0.010 |
Why?
|
Antigens, Surface | 1 | 2001 | 1617 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2005 | 4860 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 2000 | 2014 | 0.010 |
Why?
|
Gene Transfer Techniques | 1 | 2001 | 1216 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2005 | 4108 | 0.010 |
Why?
|
Enterobius | 1 | 1995 | 1 | 0.010 |
Why?
|
Antibody Formation | 1 | 2000 | 1391 | 0.010 |
Why?
|
Taiwan | 1 | 1997 | 521 | 0.010 |
Why?
|
Oligonucleotide Probes | 1 | 1995 | 417 | 0.010 |
Why?
|
Anthelmintics | 1 | 1995 | 83 | 0.010 |
Why?
|
Extracellular Matrix Proteins | 1 | 1999 | 833 | 0.010 |
Why?
|
DNA Primers | 1 | 1999 | 2825 | 0.010 |
Why?
|
Immunity, Cellular | 1 | 2000 | 1555 | 0.010 |
Why?
|
Larva | 1 | 1995 | 511 | 0.010 |
Why?
|
Cell Division | 1 | 2000 | 4475 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2000 | 6113 | 0.010 |
Why?
|
Up-Regulation | 1 | 2001 | 4137 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 1999 | 3750 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1999 | 3807 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2001 | 3404 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2001 | 5881 | 0.010 |
Why?
|
Age of Onset | 1 | 1997 | 3344 | 0.010 |
Why?
|
Models, Genetic | 1 | 1999 | 3449 | 0.000 |
Why?
|
Gene Expression | 1 | 2001 | 7584 | 0.000 |
Why?
|
Diarrhea | 1 | 1995 | 1316 | 0.000 |
Why?
|
Colloids | 1 | 1987 | 122 | 0.000 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1999 | 10729 | 0.000 |
Why?
|
Immunologic Techniques | 1 | 1987 | 212 | 0.000 |
Why?
|
Odds Ratio | 1 | 1997 | 9649 | 0.000 |
Why?
|
Base Sequence | 1 | 1995 | 12403 | 0.000 |
Why?
|
Myocardial Infarction | 1 | 2005 | 11499 | 0.000 |
Why?
|
Microscopy, Electron | 1 | 1987 | 2548 | 0.000 |
Why?
|
Cells, Cultured | 1 | 1999 | 18973 | 0.000 |
Why?
|
Gold | 1 | 1987 | 482 | 0.000 |
Why?
|
Models, Biological | 1 | 1999 | 9443 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1995 | 17594 | 0.000 |
Why?
|